RxDoctor Payments Data

Carli Turngren

Psychiatric/Mental Health · Pittsburgh, PANPI 1154056943

Payments from drug & device makers

$1,049in general payments, 2019–2025

Across 40 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$324
  • Otsuka America Pharmaceutical, Inc.$174
  • Alkermes, Inc.$162
  • AbbVie$148
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
  • Neurocrine Biosciences, Inc.$66
  • plus $49 from 2 others

What the payments were for

  • Food & beverage$83980%
  • Education$20920%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,049 in reported general payments places this provider in the 65th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$10,129
Medicare patients
54
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate15$40,122
VraylarCariprazine Hcl14$17,172
LatudaLurasidone Hcl11$14,605
Clomipramine Hcl15$1,884
Doxepin Hcl25$1,744
Aripiprazole68$1,646
Buspirone Hcl52$1,240
Divalproex Sodium ErDivalproex Sodium19$1,191
Quetiapine Fumarate90$952
Venlafaxine Hcl ErVenlafaxine Hcl47$951
Fluoxetine Hcl50$915
Escitalopram Oxalate64$887
Perphenazine15$644
Olanzapine51$628
Trazodone Hcl74$608

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$27$40,12215 claims
AbbVieVraylar$148$17,17214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →